Washington University Molecular Core Organization and Services The Siteman Cancer Center Molecular Core Lab and the accredited BJC Clinical Molecular Diagnostic Lab share 2500 sq. ft. In the Barnes- Jewish North campus building. The lab site is integrated into the clinical lab division and routinely receives, accessions, processes, and stores clinical specimen material Mon-Fri. The Molecular Analysis Core lab directed by Barbara Zehnbauer, PhD FACMG directly supervises a staff of 44 senior research technologists with extensive expertise (each at least 5 years) in clinical molecular diagnostics and mutation detection for both cancer and inherited genetic disorders. This is an integrated laboratory structure of hospital clinical lab technologists and a dedicated developmental research technologist. The Molecular Diagnostic lab of (BJC & WUSM) provides receipt, preparation, and processing of specimens for Cancer Center clinical trials in accredited clinical lab environment with CLIA and CAP approved procedures, policies, and QA/QC standards of operation to ensure accurate testing. Equipment This is a state of the art molecular genetics facility comprising about 2500 sq. ft with thermalcyclers. (96 and 384 well format) centrifuges, refrigerators, freezers, agarose & acrylamide gel electrophoresis, fluorescent & digital gel photography, transilluminator, Southern hybridization ovens, water baths, Template TM PCR hoods, may micro- pipettors, gel driers, evaporator concentrators. Personal computers & software packages for data management are in place, including; a stand- alone custom database management package for compiling, tracking, and reporting on assay results an automated fluorescent DNA sequencer, fragment analyzer, and software; HP scanner and signal quantitation software; protein PAGE rigs; and automated & multi-channel pipettors. All investigations are performed under the requirements of clinical alb quality assurance and quality control with particular emphasis on well- defined and validated procedures, policies, and containment guidelines. This assures a high accuracy of specimen analysis avoid mishandling or contamination of test regents and samples. University of Southern California Core University of Southern California molecular analysis core is located in the laboratory of Dr. Sue Ingles in the USC Norris Cancer Center The laboratory has 100 sq. feet of space (Room 6419) that is well integrated with the clinical laboratory division and the sample processing system. The Molecular Analysis Core Laboratory is directed by Sue Ingles, D.PH., who directly supervises the staff of Senior Research Technologists with extensive experience in clinical molecular diagnostic and mutation detection for both cancer and other medical disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01GM063340-02
Application #
6659301
Study Section
Special Emphasis Panel (ZRG1)
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Marsh, Sharon; King, Cristi R; Van Booven, Derek J et al. (2015) Pharmacogenomic assessment of Mexican and Peruvian populations. Pharmacogenomics 16:441-8
Patel, Jai N; Jiang, Chen; Hertz, Daniel L et al. (2015) Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Cancer 121:1025-31
Hariani, Gunjan D; Lam, Ernest T; Lam, Ernest J et al. (2014) Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics. BMC Res Notes 7:360
McWhinney-Glass, Sarah; Winham, Stacey J; Hertz, Daniel L et al. (2013) Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity. Clin Cancer Res 19:5769-76
Trammel, Morgan; Roederer, Mary; Patel, Jai et al. (2013) Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists? Curr Oncol Rep 15:276-85
Motsinger-Reif, Alison A; Jorgenson, Eric; Relling, Mary V et al. (2013) Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics 23:383-94
Crowley, James J; Kim, Yunjung; Szatkiewicz, Jin Peng et al. (2012) Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice. Mamm Genome 23:322-35
He, Y J; McLeod, H L (2012) Ready when you are: easing into preemptive pharmacogenetics. Clin Pharmacol Ther 92:412-4
Hoskins, Janelle M; Ong, Pei-Shi; Keku, Temitope O et al. (2012) Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome. PLoS One 7:e41954
Crowley, J J; Adkins, D E; Pratt, A L et al. (2012) Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice. Pharmacogenomics J 12:147-55

Showing the most recent 10 out of 181 publications